Highlights and Quick Summary
- Capital Stock Change for the quarter ending December 31, 2022 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Capital Stock Change decreased by -100.0%
- Annual Capital Stock Change for 2022 was $1 Thousand (a -100.0% decrease from previous year)
- Annual Capital Stock Change for 2021 was $122 Million (a 246.42% increase from previous year)
- Annual Capital Stock Change for 2020 was $35.1 Million (a 407.18% increase from previous year)
- Twelve month Capital Stock Change ending December 31, 2022 was $1 Thousand (a -83.33% decrease compared to previous quarter)
- Twelve month trailing Capital Stock Change decreased by -99.8% year-over-year
Trailing Capital Stock Change for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $1 Thousand | $6 Thousand | $357 Thousand | $498 Thousand |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capital Stock Change of Precigen, Inc.
Most recent Capital Stock Changeof PGEN including historical data for past 10 years.Interactive Chart of Capital Stock Change of Precigen, Inc.
Precigen, Inc. Capital Stock Change for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2021 | $0.01 | $0.35 | $0.14 | $121.16 | $121.65 |
| 2020 | $0.05 | $0.0 | $0.07 | $35.0 | $35.12 |
| 2019 | $0.0 | $0.01 | $0.0 | $6.92 | $6.92 |
| 2018 | $1.26 | $0.14 | $0.61 | $88.31 | $90.33 |
| 2017 | $13.8 | $0.19 | $0.5 | $0.18 | $14.67 |
| 2016 | $0.99 | $0.51 | $7.89 | $9.78 | $19.17 |
| 2015 | $2.25 | $220.02 | $7.82 | $112.61 | $342.7 |
| 2014 | $0.22 | $0.3 | $0.65 | $25.33 | $26.49 |
| 2013 | $0.36 | $168.85 | $85.59 | $64.42 | $319.22 |
| 2012 | $0.07 | $50.74 | – | – | $76.03 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology